Dr Zaklina Kovacevic

Therapeutic Targeting of the Potent Metastasis Suppressor, NDRG1, in Pancreatic Cancer

Grant

Therapeutic Targeting of the Potent Metastasis Suppressor, NDRG1, in Pancreatic Cancer

Award

2017 Innovation Grant - Dean Gorddard Grant

Institution

The University of Sydney

Principal Investigator

Dr Zaklina Kovacevic, DVCR Senior Research Fellowship, Senior Lecturer (Research) at the University of Sydney

Time required to complete project

1 year

Project Summary

The stromal tissue surrounding pancreatic cancer is a major driver of metastasis and therapeutic resistance. This project will examine a novel frontier drug in clinical trials that up-regulates the potent metastasis suppressor, NDRG1, and its role in inhibiting the oncogenic cross-talk between pancreatic cancer cells and the surrounding stroma.

Dr Zaklina Kovacevic, Sydney University

Research Reports
Click to download progress reporting on the outcomes of this research.

Final Report

Progress Report

The Dean Gorddard Grant

This grant was awarded by Dean Gorddard who, along with the support of his friend Craig Ryman at AMP, successfully raised over $100k in support of the Avner Pancreatic Cancer Foundation. Dean, Craig and the team at AMP achieved this significant amount by organising various fundraising initiatives including taking part in the 2017 City2Surf run, marathons, fundraising dinners and raffles. Dean was diagnosed with the disease in 2015 and tragically lost his battle to Pancreatic Cancer in 2018.